BIRC5 and lung adenocarcinoma: Napsin A is a good prognostic marker while Survivin stands as a poor one for lung adenocarcinoma with a statistically inverse relation between the two, which means that Napsin A can’t be used as a marker for diagnosing poorly differentiated tumors.